FGFR2 rs2987983: Understanding Breast Cancer Risk Associations

What each genotype means

What is the rs2987983 Variant?

The rs2987983 variant is a single nucleotide polymorphism, or SNP, which is a common type of genetic variation where a single "letter" of DNA differs between individuals. This specific SNP is located within the FGFR2 gene, which provides instructions for making a protein called fibroblast growth factor receptor 2. In the context of human genetics, researchers study these variations to understand how they might influence biological processes. When a SNP like rs2987983 is identified as being associated with a health condition, it means that individuals carrying a particular version of this DNA sequence may show a statistically different likelihood of developing that condition compared to those who do not. It is important to note that this is a statistical association observed in large population studies, not a direct cause-and-effect relationship that applies to every individual.

The Role of the FGFR2 Gene

The FGFR2 gene is essential for normal human development and cellular function. It encodes a receptor protein that sits on the surface of cells and receives signals from the environment, helping to regulate processes such as cell growth, division, and maturation. Because of its critical role in these fundamental cellular activities, the FGFR2 gene is highly active in many different tissues throughout the body. When the function of this receptor is altered, it can potentially impact how cells respond to growth signals. In the context of cancer research, scientists are particularly interested in how variations in this gene might influence the behavior of breast tissue cells. Understanding the normal function of FGFR2 helps researchers hypothesize why certain genetic variations might be linked to an increased susceptibility to breast cancer, often focusing on how these changes might affect hormone-dependent signaling pathways.

Research and Evidence Strength

The association between variants in the FGFR2 gene and breast cancer risk is supported by strong evidence from numerous genome-wide association studies (GWAS). These large-scale studies compare the DNA of thousands of individuals with and without breast cancer to identify genetic markers that appear more frequently in the affected group. The FGFR2 locus has been consistently identified as a significant risk factor across diverse populations. While the statistical evidence linking these variants to breast cancer is robust, the exact biological mechanism—how the variant actually changes cellular behavior to increase risk—is still a subject of ongoing scientific investigation. Researchers often note that these associations are frequently linked to estrogen receptor-positive breast cancers, suggesting that the variant may interact with hormonal pathways. It is a classic example of how complex traits are influenced by multiple genetic factors working in concert with environmental and lifestyle influences.

Population Frequency and Distribution

The rs2987983 variant is considered a common genetic variation, meaning it is found at a relatively high frequency across many different human populations. Because it is common, a large portion of the general population carries at least one copy of the risk-associated allele. Genetic studies have confirmed its presence and its association with breast cancer risk in various ethnic and ancestral groups, though the specific frequency of the alleles can vary slightly between populations. This widespread distribution is typical for many common SNPs identified by GWAS. Because the variant is so common, it is important to view it as one of many factors that contribute to an individual's overall risk profile, rather than a rare mutation that dictates health outcomes on its own. Most people carry many common variants that slightly increase or decrease their risk for various common diseases.

Interpreting Your Genetic Information

If you have information about your genotype for rs2987983, it is important to understand what this means in a clinical context. Genetic associations identified in research studies are used to understand population-level risks, not to provide individual medical diagnoses or predictions. Having a specific genotype does not mean you will or will not develop breast cancer; rather, it is one small piece of a much larger puzzle that includes family history, lifestyle, and other genetic factors. You cannot change your genotype, but you can use information about your health and family history to have informed conversations with your healthcare provider. If you are concerned about your breast cancer risk, the most effective step is to consult with a doctor or a genetic counselor. They can help you interpret your overall risk profile and discuss appropriate screening or preventative strategies based on your personal health history.

Frequently asked questions

Sources & further reading

Related variants in FGFR2